Comparing Myopia Control Efficacy in Children With 4 Methods: Orthokeratology, DIMS, DISK, and SVS.
NCT ID: NCT06654180
Last Updated: 2024-10-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
100 participants
INTERVENTIONAL
2022-10-21
2031-12-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Does orthokeratology slows the progressing myopia more significant than the DIMS or DISK? What medical problems do participants have when taking orthokeratology, DIMS and DISK? Researchers will compare all the 3 interventions to a placebo (SVS) to see if 3 interventions has significant difference in slow the axial length elongation as well as the refraction changes.
Participants will:
Take orthokeratology, DIMS, DISK or SVS every day for 12 months Visit the clinic once every 3 months for checkups and tests.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Myopia Control in Children: Comparison of Defocus Incorporated Multiple Segments® Lenses Versus Atropine 0.05% Eyedrops
NCT05062031
Defocus (DIMS) Spectacles Versus Ortho-K Lenses (OKL) for Slowing Myopia Progression in Children Aged 6-12 Years.
NCT05134935
Clinical Study on the Effectiveness of Diverse Segments Defocus Optimization in Spectacle Lenses for Slowing Myopia Progression
NCT07323251
3D Designed Defocus Lenses on Myopia Control in Children and Adolescents
NCT07284147
A Clinical Trial to Evaluate the Efficacy and Safety of Defocusing Lenses in Delaying Myopia Progression
NCT06411717
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Orthokeratology
To wear Orthokeratology at night to slow down progressing myopia
Orthokeratology
Orthokeratology is to a rigid contact lens with reverse design to flat the central cornea to correct the myopia, which is to use at night during sleep; DIMS and SVS are both spectacles to wear at daytime; DIMS has many tiny lenses at peripheral of the big lenses to make the peripheral retina myopic defocus during the daytime; SVS has only one focus while DIMS has many focuses made by the tiny segments lenses around the peripheral vision fields; DISK is a soft contact lens with peripheral myopic power design to make the myopic eyes defocus at peripheral during the daytime.
defocus-incorporated multiple segment lenses (DIMS) spectacles
To wear defocus-incorporated multiple segment lenses (DIMS) spectacles at daytime
defocus-incorporated multiple segment lenses (DIMS) spectacles
It is the special lenses with peripheral lots of tiny segments of plus lenses around the center
defocus incorporated soft contact (DISK) lenses
To wear defocus incorporated soft contact (DISK) lenses at daytime
DISK
SVS
single-vision spectacles (SVS)
To wear SVS at daytime and at night before sleep
Single-focus spectacles
Myopic Glasses with mono-focus in each eye
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Orthokeratology
Orthokeratology is to a rigid contact lens with reverse design to flat the central cornea to correct the myopia, which is to use at night during sleep; DIMS and SVS are both spectacles to wear at daytime; DIMS has many tiny lenses at peripheral of the big lenses to make the peripheral retina myopic defocus during the daytime; SVS has only one focus while DIMS has many focuses made by the tiny segments lenses around the peripheral vision fields; DISK is a soft contact lens with peripheral myopic power design to make the myopic eyes defocus at peripheral during the daytime.
defocus-incorporated multiple segment lenses (DIMS) spectacles
It is the special lenses with peripheral lots of tiny segments of plus lenses around the center
DISK
SVS
Single-focus spectacles
Myopic Glasses with mono-focus in each eye
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Must have cycloplegic refraction with spherical equivalent refractive (SER)
* \- 2.00 D \~ - 5.00 D (including the boundary values)
* Clinical diagnosis of astigmatism was ≤ 1.00D
* Must be able to have corrected visual acuity ≤ 0.00 logMAR of either eye
* Must be able to wear either of SVS/DIMS/DISC/Orthokeratology lenses and kept the same intervention for 12 month
* Must have the front cornea curve value between 41.00D\~44.00D
* Must have axial length of the study eye between 23.00mm and 25.00mm at baseline
Exclusion Criteria
* keratitis
* Conjunctivitis
* Clinical diagnosis of entropion
* Clinical diagnosis of glaucoma
* Clinical diagnosis of retinal lesions
* Clinical diagnosis of amblyopia
* Clinical diagnosis of optic media lesions (e.g., central thick corneal scars, cataract)
* Clinical diagnosis of optic nerve dysfunction
* Have medical history of atropine eyedrops (including 1% high concentration , 0.05%, 0.01% or other low concentration)
* Have history of wearing peripheral defocus spectacles
* Have history of wearing duo-focal soft contact lenses
* Unable to follow up
* Investigators consider to be not eligible.
8 Years
13 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ningbo Eye Hospital
OTHER
Kaikai QIU
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kaikai QIU
Researcher
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ningbo Eye Hospital
Ningbo, Zhejiang, China
Optometry department, Ningbo Eye Hospital
Ningbo, Zhejiang, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
MR-33-22-012252
Identifier Type: REGISTRY
Identifier Source: secondary_id
Southeast Eye Institute
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.